David Segarnick helms our Medical Strategy team within Medical Analytics & Innovation. He has been in the trenches of many major blockbuster and rare disease product launches over the past 25 years, providing a pharmacological and clinical strategy to support product differentiation. David has extensive medical communications and business development experience across multiple therapeutic areas. He is also a professor of Pharmacology, Physiology & Neuroscience at the Rutgers University/New Jersey Medical School, where he teaches pharmacology and pharmaceutical marketing. David has authored more than two dozen articles in peer-reviewed medical journals and has contributed several chapters in medical textbooks.